D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 129 SEK -1.9% Market Closed
Market Cap: 2.1B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Balance Sheet

Balance Sheet Decomposition
Devyser Diagnostics AB

Current Assets 258.9m
Cash & Short-Term Investments 171.4m
Receivables 49.5m
Other Current Assets 38m
Non-Current Assets 204m
PP&E 100m
Intangibles 82.9m
Other Non-Current Assets 21.1m
Current Liabilities 61.5m
Accounts Payable 10.1m
Accrued Liabilities 26.2m
Other Current Liabilities 25.2m
Non-Current Liabilities 52.4m
Long-Term Debt 47.5m
Other Non-Current Liabilities 4.9m

Balance Sheet
Devyser Diagnostics AB

Rotate your device to view
Balance Sheet
Currency: SEK
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
8
10
8
378
364
263
Cash Equivalents
8
10
8
378
364
263
Total Receivables
15
17
25
26
33
45
Accounts Receivables
14
16
16
19
28
34
Other Receivables
1
1
9
8
6
12
Inventory
4
4
5
7
10
21
Other Current Assets
1
1
1
2
5
13
Total Current Assets
28
32
40
413
412
342
PP&E Net
4
18
16
17
31
92
PP&E Gross
4
18
16
17
31
92
Accumulated Depreciation
3
5
8
10
15
24
Intangible Assets
15
20
14
18
33
49
Goodwill
0
0
0
0
7
7
Note Receivable
0
0
0
0
0
0
Long-Term Investments
0
0
0
2
0
0
Other Long-Term Assets
2
2
5
7
18
21
Other Assets
0
0
0
0
7
7
Total Assets
48
N/A
74
+53%
74
+1%
457
+514%
501
+10%
510
+2%
Liabilities
Accounts Payable
3
3
6
10
10
14
Accrued Liabilities
4
4
8
13
21
20
Short-Term Debt
0
0
2
0
0
0
Current Portion of Long-Term Debt
1
3
4
3
6
18
Other Current Liabilities
1
5
8
4
16
11
Total Current Liabilities
10
16
28
29
51
63
Long-Term Debt
8
20
15
10
16
57
Deferred Income Tax
0
0
0
0
0
0
Other Liabilities
0
0
1
1
2
5
Total Liabilities
18
N/A
37
+101%
44
+19%
40
-8%
69
+72%
125
+81%
Equity
Common Stock
0
0
1
1
1
1
Retained Earnings
8
1
12
33
78
130
Additional Paid In Capital
38
38
43
449
508
513
Other Equity
0
0
0
0
1
1
Total Equity
30
N/A
37
+23%
31
-17%
417
+1 254%
431
+4%
385
-11%
Total Liabilities & Equity
48
N/A
74
+53%
74
+1%
457
+514%
501
+10%
510
+2%
Shares Outstanding
Common Shares Outstanding
15
15
15
15
16
16

See Also

Discover More